Assistant Professor, Urology, UCSF School of Medicine

Urology

Kirsten L. Greene is an expert in the field of Urology. She researched medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is one of the top medical schools in the US. Johns Hopkins University School of Medicine has a rank of 3 in research and a 29 in primary care She received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Dr. Kirsten L. Greene has written publications. She has 28 publications published with PubMed. The lastest publication is: 'Extended Follow-Up and Risk Factors for Disease Reclassification from a Large Active Surveillance Cohort for Localized Prostate Cancer.' She accepts Medicare payments and is listed with Medicare.gov.

Publications

---

• Extended Follow-Up and Risk Factors for Disease Reclassification from a Large Active Surveillance Cohort for Localized Prostate Cancer.
• Evolution and Immediate Future of US Screening Guidelines.
• Semiautomatic registration of digital histopathology images to in vivo MR images in molded and unmolded Prostates.
• Early Detection of Prostate Cancer: AUA Guideline.
• Patient Demographics, Quality of Life, and Disease Features of Men With Newly Diagnosed Prostate Cancer: Trends in the PSA Era.
• How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate Cancer?
• Proximal bulbar periUrethral abscess.
• Prostate specific antigen best practice statement: 2009 update.
• PSA screening: determinants of primary-care physician practice patterns.
• Changes in Prostate Cancer Grade on Serial Biopsy in Men Undergoing Active Surveillance.
• The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate Cancer.
• Outcomes of active surveillance for men with intermediate-risk prostate Cancer.
• Prostate specific antigen screening for prostate Cancer: Knowledge of, attitudes towards, and utilization among primary care physicians.
• The E-cadherin -160 C/A polymorphism and prostate Cancer risk in white and black American men.
• Diagnostic Utility of the ImmunoCyt/uCyt+ Test in Bladder Cancer.
• Surgery or assisted reproduction? A decision analysis of treatment costs in male infertility.
• CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate Cancer.
• Validation of the Kattan preoperative nomogram for prostate Cancer recurrence using a community based cohort: results from Cancer of the prostate strategic urological ...
• Laparoscopic-assisted upper pole ureterocalicostomy using Renal inversion and autotransplantation.
• MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in Bladder cancer.
• Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules.
• Surgical management after active surveillance for low-risk prostate Cancer: pathological outcomes compared with men undergoing immediate treatment.
• Pelvic lymphadenectomy in prostate Cancer.
• Traditional Foley drainage systems--do they drain the Bladder?
• Impact of androgen deprivation on physical well-being in patients with prostate Cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research E...
• Who is the average patient presenting with prostate Cancer?
• Prostate biopsy tumor extent but not location predicts recurrence after radical Prostatectomy: results from CaPSURE.

Schools

---

• Johns Hopkins University School Of Medicine

• University Ca Sf School Of Med

Procedures Preformed

---

• AdRenalectomy
• Complete Nephrectomy With Robotic Assistance
• Cystectomy
• Cystotomy
• View All

Conditions Treated

---

• Bladder Cancer
• Bladder Infection
• Bladder Stones
• Blood in Semen (Hematospermia)
• View All

Doctors Specialties

---

• Urology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification
• Fellow (FACS)

Education

---

• UCSF
• Johns Hopkins University School of Medicine

Hospital

---

• San Francisco General Hospital and Trauma Center
• San Francisco VA Medical Center
• UCSF Medical Center

Drug Facts

---

NPI NUMBER		1023119013
NPPES Provider LastName		GREENE
NPPES Provider FirstName		KIRSTEN
NPPES Provider ZIPCode		941153010
NPPES Provider State		CA
Specialty Description		Urology
Total Claim Count		588.0
Distinct Opioid Count		1.0
Opioid Claim Count		15.0
Percent Opioid Claims		2.55

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1023119013
Last Name Of The Provider	GREENE
First Name Of The Provider	KIRSTEN
View All

Similar Doctors

---

	Dr. Anobel Y. Odisho, MD This Doctor is OpenDoctor Recommended.
	Dr. Emil A. Tanagho, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Robert S. Safran, MD This Doctor is OpenDoctor Recommended.
	Dr. Ronald K. Smialowicz, MD
	Dr. Katsuto Shinohara, MD This Doctor is OpenDoctor Recommended.
	Dr. Carlos J. Felix Fretes, MD This Doctor is OpenDoctor Recommended.
	Dr. Benjamin N. Breyer, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. David B. Bayne, MD
	Dr. Rachel S. Edlin, MD This Doctor is OpenDoctor Recommended.
	Dr. Adam J. Gadzinski, MD
	Dr. Selma Masic, MD This Doctor is OpenDoctor Recommended.
	Dr. Samuel L. Washington III, MD
	Dr. Glen Yang, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog